Interferon alpha-2 (IFN alpha 2) increases lacrimal and salivary function in Sjögren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine. (Q41930476)
Jump to navigation
Jump to search
scientific article published on July 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Interferon alpha-2 (IFN alpha 2) increases lacrimal and salivary function in Sjögren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine. |
scientific article published on July 1996 |
Statements
Interferon alpha-2 (IFN alpha 2) increases lacrimal and salivary function in Sjögren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine (English)
G F Ferraccioli
F Salaffi
S De Vita
L Casatta
C Avellini
M Carotti
C A Beltrami
C Cervini